Generate a tailored SOP for Dr. Donato Santovito. Improve your application with a focused, well-structured draft.
Donato Santovito is a Principal Investigator at IPEK University, leading the Santovito Lab focused on translational vascular therapy. His research encompasses the study of epigenetics, autophagy, and atherosclerosis in the context of cardiovascular diseases. The lab aims to uncover molecular mechanisms that could be used as therapeutic targets or diagnostic markers to enhance standard care for these conditions. Santovito's investigations include how microRNAs function and interact with various epigenetic regulatory mechanisms that affect cell communication, particularly between stromal immune cells and the vascular wall. He explores the cross-talk of epigenetic layers in regulating vascular cells and the role of autophagy in cell homeostasis, especially under pathological stimuli. With a commitment to education, he also mentors Master and PhD students in human biology and advanced therapies. His work contributes significantly to understanding the cellular processes that underlie cardiovascular health and disease, paving the way for new therapeutic strategies.
Santovito Lab, IPEK University • Munich, Germany
Leading a research group focused on translational vascular therapy.